Jose Campoamor
Pain Medicine · Naples, FLNPI 1417994575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations.
Across 136 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$429
- Scilex Pharmaceuticals Inc.$367
- Abbott$284
- Teva Pharmaceuticals USA, Inc.$276
- Biodelivery Sciences International, Inc.$219
- Pfizer$181
- plus $977 from 16 others
Across 1 payment — averaging $7400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pacira Therapeutics, Inc.$7K
What the payments were for
- Food & beverage$2,734100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 19 | $429 |
| Scilex Pharmaceuticals Inc. | 22 | $367 |
| Abbott | 8 | $284 |
| Teva Pharmaceuticals USA, Inc. | 12 | $276 |
| Biodelivery Sciences International, Inc. | 18 | $219 |
| Pfizer | 9 | $181 |
| Biohaven Pharmaceuticals, Inc. | 4 | $147 |
| Daiichi Sankyo Inc. | 3 | $147 |
| AbbVie(2 entities) | 8 | $127 |
| Pacira Therapeutics, Inc. | 5 | $98 |
| Amgen(2 entities) | 6 | $96 |
| Nevro Corp. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Novartis | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Redhill Biopharma Inc. | 2 | $34 |
| Fidia Pharma USA Inc. | 2 | $24 |
| Sentynl Therapeutics, Inc. | 2 | $24 |
| Pernix Therapeutics Holdings, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$140
- Morphabond ER$121
- Proclaim Family of SCS IPGs$116
- NURTEC ODT$112
How this compares
$2,734 in reported general payments places this provider in the 55th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Naples
- Joseph PergolizziNaples$333K
- Jeffrey GudinMiami$356K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
- Nicholas BremerFernandina Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.